Aegis's Clinical Update Webinar

Aegis's Clinical Update Webinar

Register for Aegis's Clinical Update Webinar

Expansion of Urine Behavioral Health Drug Testing, AcuRiseID™

[Duration: 15 minutes] 

Takeaways include:

  • Medication non-adherence in the behavioral health population increases the risk of relapse, hospitalization, and overall costs.
  • Urine behavioral health drug testing is now offered for over 100 medications and illicit drugs, designed for mental health and recovery care providers' unique needs.
  • AcuRiseID™ is an objective medication monitoring tool for measuring treatment adherence and potential substance use.
  • Medication adherence improves symptoms and quality of life in behavioral health patients.

Presented by: 

Hina Patel, Pharm.D., MBA, BCGP
Aegis Sciences Corporation

 

Thursday, February 25, 2021

10:00 AM Central
Register Now

1:00 PM Central
Register Now

Choose from two live presentation times. Click the register button on the WebEx page to complete the form. The meeting link will be emailed to you upon registration.